The Leukodystrophy Center (LC) at Weill Cornell Medicine is comprised of a multidisciplinary team which provides comprehensive medical care to both children and adults affected by a leukodystrophy. Allied with the New York State Newborn Screening Program, we specialize in the imaging surveillance of patients identified by newborn screening. In partnership with Memorial Sloan Kettering Cancer Center, our Metabolic Cell and Gene Therapy Program provides expertise in hematopoietic stem cell transplantation specifically for neurometabolic disease.
The LC is a Leukodystrophy Care Network Certified Center. The Leukodystrophy Care Network (LCN) is a community of affected families, organizations and medical providers committed to revolutionizing the health and quality of life of individuals affected by Leukodystrophies with proactive, innovative, and comprehensive medical care standards and specialized centers. To learn more, please visit the Leukodystrophy Care Network website.
Primary Contact: Rebecca Espinosa, Administrative Specialist
Mailing Address: 525 E68th St, Box 91, NYC, NY 10065
Location: Pediatric Sub-Specialty Practice, Helmsley Medical Building, 505 East 70th Street, 3rd Floor, New York, NY 10021
Day: Monday mornings
Location: NewYork-Presbyterian Hospital, 520 East 70th Street, Starr Pavilion, Room 607
New York, NY 10021
Journal of Inherited Metabolic Disease Podcast: All About X-ALD featuring our work and the work of our collaborators
Journal of Inherited Metabolic Disease Visual Abstract featuring our publication on the MRI Surveillance of Boys with X‐linked Adrenoleukodystrophy Identified by Newborn Screening